Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 92.42 USD -0.23%
Market Cap: 115.1B USD
Have any thoughts about
Gilead Sciences Inc?
Write Note

Relative Value

The Relative Value of one GILD stock under the Base Case scenario is 83.95 USD. Compared to the current market price of 92.42 USD, Gilead Sciences Inc is Overvalued by 9%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GILD Relative Value
Base Case
83.95 USD
Overvaluation 9%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
72
Median 3Y
3.4
Median 5Y
3.2
Industry
8.1
Forward
4
vs History
0
vs Industry
1
Median 3Y
17.8
Median 5Y
17.8
Industry
23
Forward
21.4
vs History
12
vs Industry
12
Median 3Y
10.4
Median 5Y
8.9
Industry
23.4
vs History
68
vs Industry
9
Median 3Y
13.2
Median 5Y
12.9
Industry
27.3
vs History
0
vs Industry
17
Median 3Y
4.5
Median 5Y
4.1
Industry
2.6
vs History
36
vs Industry
58
Median 3Y
3.9
Median 5Y
3.8
Industry
8.1
Forward
3.8
vs History
30
vs Industry
54
Median 3Y
5.1
Median 5Y
4.7
Industry
9.6
vs History
25
vs Industry
10
Median 3Y
8.5
Median 5Y
8.7
Industry
4.3
Forward
13.1
vs History
55
vs Industry
8
Median 3Y
10.3
Median 5Y
10.6
Industry
3.8
Forward
14.4
vs History
44
vs Industry
10
Median 3Y
11.6
Median 5Y
10.6
Industry
6
vs History
49
vs Industry
8
Median 3Y
12.4
Median 5Y
11.2
Industry
3.8
vs History
7
vs Industry
46
Median 3Y
2
Median 5Y
2
Industry
4.8

Multiples Across Competitors

GILD Competitors Multiples
Gilead Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
33.8B USD 16.1 -101.7 -244.6 -170.3
P/E Multiple
Earnings Growth
US
Gilead Sciences Inc
NASDAQ:GILD
Average P/E: 211.8
910.1
75%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -101.7 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Gilead Sciences Inc
NASDAQ:GILD
Average EV/EBITDA: 17.9
10.1
12%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -244.6 N/A
EV/EBIT Multiple
EBIT Growth
US
Gilead Sciences Inc
NASDAQ:GILD
Average EV/EBIT: 23.2
10.1
29%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -170.3 N/A

See Also

Discover More
Back to Top